Crossref
CDK4/6 inhibition in pancreatic cancer: lessons learned as the therapeutic landscape evolves
Annals of Pancreatic Cancer · 2026-05 · 9 · 13-13
DOI: 10.21037/apc-26-0011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Pancreatic Cancer, 2026-05. Verfasst von Shreyas Kalantri und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kalantri, S., & Smaglo, B. (2026). CDK4/6 inhibition in pancreatic cancer: lessons learned as the therapeutic landscape evolves. Annals of Pancreatic Cancer, 9, 13-13. https://doi.org/10.21037/apc-26-0011
Vancouver
Kalantri S, Smaglo B. CDK4/6 inhibition in pancreatic cancer: lessons learned as the therapeutic landscape evolves. Annals of Pancreatic Cancer. 2026;9:13-13. doi:10.21037/apc-26-0011
BibTeX
@article{Kalantri2026,
author = {Kalantri, Shreyas and Smaglo, Brandon},
title = {CDK4/6 inhibition in pancreatic cancer: lessons learned as the therapeutic landscape evolves},
journal = {Annals of Pancreatic Cancer},
year = {2026},
volume = {9},
pages = {13--13},
doi = {10.21037/apc-26-0011}
}
EUVIMED